Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs.
$2.70-4.93%
报价 2026-11-13
市值
$5.7M
EV
$-6.8M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -99.1%
$2.65$306.00
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
L2 2026-05-21全文 ↓尚未生成 L3 估值,没有三情景目标价。去生成估值 →
基本面判断
›数据时效
基于 2026-05-21 收盘价 $0.52 及 TTM 财报
›盈利指标失效
PE/EV/EBITDA 因净亏损与负 EBITDA 失去参考意义
›核心锚点
PS 0.07x 为当前唯一有效相对估值指标
历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Drug Manufacturers - Specialty & Generic| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| SBFMSunshine Biopharma, Inc. | $5.7M | -4.9% | – | 29.8% | – | – | – | |
| COSMCosmos Health Inc. | $16.3M | -22.0% | +60.2% | 10.3% | – | – | – | |
| BFRIBiofrontera Inc. | $10.4M | -24.4% | +14.7% | 82.8% | – | – | – | |
| QNTMQuantum BioPharma Ltd. | $10.4M | -9.6% | – | 0% | – | – | – | |
| SNOASonoma Pharmaceuticals, Inc. | $5.5M | -6.8% | +15.5% | 38.9% | – | – | – | |
| YCBDcbdMD, Inc. | $4.2M | -4.7% | +7.1% | 54.7% | – | – | – | |
| GELSGelteq Limited Ordinary Shares | $3.5M | -0.1% | – | 100% | – | – | – | |
| APUSApimeds Pharmaceuticals US, Inc | $3.4M | -1.8% | – | 0% | – | – | – | |
| AKANAkanda Corp. | $3.2M | +102.5% | – | -160.1% | – | – | – | |
| 同行中位数 | – | – | +15.1% | 24.6% | – | – | – |
研究全文
财务报表
暂无季度数据(首次研究运行后填充)。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。